Trial Profile
Prospective Study of Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 27 Jun 2018 New trial record